Skip to main
CI

Cigna (CI) Stock Forecast & Price Target

Cigna (CI) Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 29%
Buy 47%
Hold 24%
Sell 0%
Strong Sell 0%

Bulls say

Cigna Group is a company with promising future prospects, driven by its strong performance in the first quarter of 2026, with outperformance in MLR and growth in specialty and care segments. The exit from the Exchange market and strategic review of EviCore further demonstrate the company's focus on core growth opportunities. Additionally, the company's strong PBM and specialty pharmacy services, with key contracts and new business wins, support its positive outlook. There are some risks, such as potential government headwinds and impacts of a protracted economic downturn on commercial membership, but overall, the company's focus on high-growth areas, integration with health plans, and share repurchase activity make it a strong investment opportunity.

Bears say

Cigna Group is currently trading at the lower end of its 5-year range and below its average, which reflects the ongoing challenges in its PBM and health insurance businesses. The company's recent wins in government-sponsored businesses provide some downside protection, but its transformational spend and changing rebate economics may continue to negatively impact earnings. However, there is potential for upside in specialty businesses and health insurance MLR, which could contribute to growth in the long-term target. Overall, there are still execution risks and regulatory uncertainties that could affect the company's performance.

Cigna (CI) has been analyzed by 17 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 47% recommend Buy, 24% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cigna and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cigna (CI) Forecast

Analysts have given Cigna (CI) a Buy based on their latest research and market trends.

According to 17 analysts, Cigna (CI) has a Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $342.88, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $342.88, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cigna (CI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.